تحميل...
Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.
The Ebola virus is transmitted by direct contact with bodily fluids of infected individuals, eliciting death rates as high as 90% among infected humans. Currently, replication defective adenovirus-based Ebola vaccine is being studied in a phase I clinical trial. Another Ebola vaccine, based on an at...
محفوظ في:
المؤلفون الرئيسيون: | , , , , , , |
---|---|
التنسيق: | Artigo |
اللغة: | Inglês |
منشور في: |
Public Library of Science (PLoS)
2009-01-01
|
سلاسل: | PLoS ONE |
الوصول للمادة أونلاين: | http://europepmc.org/articles/PMC2669164?pdf=render |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|